Objective
SaveMe project will address current urgent needs for pancreatic cancer diagnosis and treatment by exploiting partners’ expertise and most recent research achievements for the design and development of novel modular nanosystems platform integrating new functionalized nano-core particles and active agents. The modular platform will enable the design of diverse active nanosystems per diagnostic or therapeutic application as defined by their active agent compositions. For diagnostics, superior tracers will be developed for molecular MR/PET and gamma camera imaging, enabling efficient diagnosis and guided surgery respectively. Novel functionalized nano-core systems will be conjugated with semi-confluent active shell layer. Three types of shell layers will be design: (1) novel iron oxide nanoparticles as advanced MRI contrast agents and/or (2) DOTA complexes for MRI (with Gd3+), or PET (with Ga-68), or gamma camera (with Ga-69); (3) Integrating within one tracer both iron oxide nanoparticles and DOTA-Ga-68 complexes for a sequential or simultaneous MR/PET imaging. For therapeutics, active nanosystems will be developed to deliver (1) therapeutic siRNAs or (2) anti-MP-inhibitory-scFVs. These non-classic anti-tumor drugs will be designed based on an extensive tumor degradome analysis for combining blockage of selective matrix MPs, thus preventing basic invasive and metastasis steps, with siRNA based neutralization of secondary molecular effects induced by the specific protease inhibition. Individualized degradome analysis will be developed for potential profiling of anti-MP and siRNAs based therapy per patient. To facilitate the above diagnostics and therapeutic effects, advanced tumor targeting and penetration active agents will be linked to nano-core functionalized groups, including a biocompatible PEG layer linked to tumor selective MMP substrate molecules and highly safe and potent novel somatostatin analogue peptides targeting SSTR overexpression.
Fields of science
- medical and health sciencesclinical medicinesurgery
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsoptical sensors
- medical and health sciencesclinical medicineradiologynuclear medicine
- engineering and technologynanotechnologynano-materials
- medical and health sciencesclinical medicineoncologypancreatic cancer
Programme(s)
Call for proposal
FP7-NMP-2010-LARGE-4
See other projects for this call
Funding Scheme
CP-IP - Large-scale integrating projectCoordinator
69978 Tel Aviv
Israel
See on map
Participants (22)
1160 WIEN
See on map
69120 Heidelberg
See on map
52900 Ramat Gan
See on map
40126 Bologna
See on map
60323 Frankfurt Am Main
See on map
115193 MOSKVA
See on map
20014 San Sebastian
See on map
20009 San Sebastian
See on map
Participation ended
50059 SOVIGLIANA VINCI
See on map
52621 Ramat Gan
See on map
NR4 7TJ Norwich
See on map
81675 Muenchen
See on map
3000 Leuven
See on map
7610001 Rehovot
See on map
117997 MOSCOW
See on map
Participation ended
W13 0BY London
See on map
20139 MILANO MI
See on map
Participation ended
752 28 Uppsala
See on map
7608665 Rehovot
See on map
75183 UPPSALA
See on map
SO15 2BG SOUTHAMPTON
See on map
50053 Sovigliana
See on map